Stephen J. Carriere
Nessuna posizione attualmente
Patrimonio netto: - $ in data 31/03/2024
Provenienza dei contatti di primo grado di Stephen J. Carriere
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Holding Company | Industrial Machinery | 11 | |
Public Company | Pharmaceuticals: Major | 9 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Stephen J. Carriere tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
DANAHER CORPORATION | Medical Specialties | Chief Tech/Sci/R&D Officer | |
INTERNATIONAL FLAVORS & FRAGRANCES INC. | Food: Specialty/Candy | Director/Board Member | |
Valo Health, Inc.
Valo Health, Inc. Financial ConglomeratesFinance Part of Valo Health LLC, Valo Health, Inc. operates as a development stage company. The private company is based in Boston, MA. The company was founded by David A. Berry. David A. Berry has been the CEO since incorporation. | Financial Conglomerates | Director/Board Member | |
HONEYWELL INTERNATIONAL INC. | Aerospace & Defense | Corporate Officer/Principal Corporate Officer/Principal | |
CURIS, INC. | Biotechnology | Corporate Officer/Principal | |
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Chief Executive Officer | |
ABBVIE INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
NEXPRISE, INC. | Miscellaneous Commercial Services | Director/Board Member | |
NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
UCB | Pharmaceuticals: Major | Corporate Officer/Principal | |
Sandoz AG
Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The private company is based in Basel, Switzerland. | Pharmaceuticals: Generic | Corporate Officer/Principal | |
Diagnostic Hybrids, Inc.
Diagnostic Hybrids, Inc. Medical SpecialtiesHealth Technology Diagnostic Hybrids, Inc. develops, manufactures and markets cellular and molecular diagnostic kits. Its products include rapid diagnostics, thyroid testing solutions, respiratory family testing, herpes family testing, chlamydia testing, enterovirus testing, cell lines and media and supplements. The company was founded by Wilfred R. Konneker, Joseph Jollick and Thomas E. Wagner in 1983 and is headquartered in Athens, OH. | Medical Specialties | Director/Board Member | |
Flagship Pioneering
Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor | |
ORYZON GENOMICS S.A. | Biotechnology | Director/Board Member | |
Florida Institute of Technology, Inc. | College/University | Undergraduate Degree | |
The University of Texas at Austin | College/University | Undergraduate Degree | |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Chief Executive Officer | |
Universidad Complutense de Madrid | College/University | Undergraduate Degree | |
Excaliard Pharmaceuticals, Inc.
Excaliard Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Excaliard Pharmaceuticals, Inc. manufactures, develops therapeutics for the treatment of scarring and fibrotic disorders. The company was founded by John Gordon Foulkes and Nicholas M. Dean in 2006 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Executive Officer | |
Basel Institute for Immunology | College/University | Corporate Officer/Principal | |
Remedy Pharmaceuticals, Inc.
Remedy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Remedy Pharmaceuticals, Inc. develops and commercializes pharmaceutical ingridients. It focuses on small molecule drugs for acute central nervous system disorders. The company was founded by David M. Geliebter and Sven M. Jacobson in 2004 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
Booz Allen Hamilton International (U.K.) Ltd.
Booz Allen Hamilton International (U.K.) Ltd. Miscellaneous Commercial ServicesCommercial Services Booz Allen & Hamilton International provides management and technology consulting services. The company provides services to international corporations and governments around the world. It was founded in 1914 and is located in McLean, VA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Harvard Medical School | College/University | Corporate Officer/Principal | |
Genrad Corp. | Corporate Officer/Principal | ||
BICYCLE THERAPEUTICS PLC | Biotechnology | Director/Board Member | |
GlaxoSmithKline AG
GlaxoSmithKline AG Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline AG is a Swiss company. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Clinical Data Interchange Standards Consortium, Inc.
Clinical Data Interchange Standards Consortium, Inc. Miscellaneous Commercial ServicesCommercial Services Clinical Data Interchange Standards Consortium, Inc. is a non-profit organization that creates clarity in clinical research by developing and advancing data standards of the highest quality. CDISC standards are required by the United States Food and Drug Administration (FDA) and Japan's Pharmaceuticals and Medical Devices Agency (PMDA), recommended by the China National Medical Products Administration (NMPA), and adopted by the world's leading research organizations. These standards enable the accessibility, interoperability, and reusability of data, maximizing the value of data for more efficient and meaningful research that has invaluable impact on health. CDISC actively collaborates with Europe's Innovative Medicines Initiative and is strategically positioned as a standards governance body that supports and maintains standards not only for clinical research but also for public health. The American company was founded by Rebecca Daniels Kush and David A. Evans has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Chairman | |
National Center for Biotechnology Information | General Government | Corporate Officer/Principal | |
WIRB- Copernicus Group, Inc.
WIRB- Copernicus Group, Inc. Miscellaneous Commercial ServicesCommercial Services WIRB- Copernicus Group, Inc. engages in the provision solutions for clinical research. The firm offers study planning and site optimization, patient engagement, scientific and regulatory, market insights, and ethical and biosafety review services. The company was founded in 2012 and is headquartered in Princeton, NJ. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
AXCA HEALPAR | Biotechnology | Chairman | |
Columbia Business School | College/University | Masters Business Admin | |
Simmons School of Management | College/University | Masters Business Admin | |
Ernest Mario School of Pharmacy | College/University | Undergraduate Degree | |
RUBIUS THERAPEUTICS | Biotechnology | Chairman | |
Cellestia Biotech AG
Cellestia Biotech AG Pharmaceuticals: MajorHealth Technology Cellestia Biotech AG manufactures anti-cancer drugs. Its pipeline product includes CB-103, a novel oral pan-NOTCH inhibitor for the treatment of NOTCH dependent leukemia, lymphoma, and solid tumors. The firm holds a worldwide exclusive license on the intellectual property rights for the development and commercialization of CB-103 and related series of close analogues. The company was founded by Freddy Radtke, Michael Bauer, Richard Peck, Dirk Weber and Rajwinder Lehal in 2014 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Remedii LLC | Corporate Officer/Principal | ||
Cogen Immune Medicine, Inc.
Cogen Immune Medicine, Inc. Pharmaceuticals: MajorHealth Technology Cogen Immune Medicine, Inc. develops immune modulation therapeutics which control immune system. Its platform includes therapeutics, vaccines, clinical decision making, and immune health. The company was founded by Noubar B. Afeyan in 2017 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Executive Officer | |
ORGANOGENESIS HOLDINGS INC. | Medical Specialties | Director of Finance/CFO | |
Tarus Therapeutics, Inc.
Tarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Portage Biotech, Inc., Tarus Therapeutics, Inc. is a private company developing small molecule inhibitors of adenosine receptors for cancer immunotherapy and select non-oncology indications. The company is based in New York, NY. The company has a comprehensive portfolio of adenosine receptor antagonists in development, including both first-in-class and programs. The company was founded by Sushant Kumar and Peter R. Molloy, with Sushant Kumar serving as CEO since incorporation. Tarus Therapeutics was acquired by Portage Biotech, Inc. on July 05, 2022 for $49.20 million. | Pharmaceuticals: Major | Director/Board Member | |
Woolsey Pharmaceuticals, Inc.
Woolsey Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Woolsey Pharmaceuticals, Inc. operates as a single-drug entity. It is focused on the treatment of rare, neurodegenerative diseases with its compound BRAVYL (Fasudil). The company was founded in 2019 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
Ring Therapeutics, Inc.
Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
Repertoire Immune Medicines, Inc.
Repertoire Immune Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services Repertoire Immune Medicines, Inc. operates as a clinical-stage biotechnology company. It focuses on the immune system to prevent, treat, and cure cancer, autoimmune disorders, and infectious diseases. The company was founded by Noubar Afeyan and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Chief Executive Officer | |
Valo Health LLC
Valo Health LLC Packaged SoftwareTechnology Services Valo Health LLC operates as a drug discovery technology company. It offers cloud computing as well as longitudinal and human data to create an entirely new drug discovery and development process. The company was founded in 2019 and is headquartered in Boston, MA. | Packaged Software | Director/Board Member | |
Pelican Harbor Seabird Station, Inc.
Pelican Harbor Seabird Station, Inc. Agricultural Commodities/MillingProcess Industries Pelican Harbor Seabird Station, Inc. is an animal care organization that focuses on the rehabilitation of vultures, which are the only known obligate scavengers in the world. Pelican Harbor Seabird Station is based in Miami. The organization offers behind-the-scenes tours, honorary adoptions, internships, and school & camp presentations. The American company also provides resources & referrals, seabird cruises, and self-guided audio tours. In addition, they have a photobiomodulation (PBMT) program that uses light therapy to relieve pain and inflammation. | Agricultural Commodities/Milling | Chairman | |
OPY ACQUISITION CORP. I | Financial Conglomerates | Director/Board Member | |
Three Opinions Foundation, Inc. | Director/Board Member | ||
SENTI BIOSCIENCES, INC. | Biotechnology | Director/Board Member |
Statistiche
Distribuzione geografica
Stati Uniti | 40 |
Svizzera | 6 |
Regno Unito | 4 |
Spagna | 3 |
Belgio | 2 |
Settori
Health Technology | 25 |
Consumer Services | 9 |
Commercial Services | 6 |
Finance | 5 |
Consumer Non-Durables | 2 |
Posizioni
Director/Board Member | 59 |
Corporate Officer/Principal | 44 |
Independent Dir/Board Member | 23 |
President | 21 |
Undergraduate Degree | 17 |
Contatti più connessi
Insiders | |
---|---|
David Epstein | 28 |
Jose-Carlos Gutiérrez-Ramos | 24 |
Paul Coppinger | 15 |
Ann Thorell | 13 |
David Perry | 13 |
Susan M. McCuaig | 12 |
Andrew Higgins | 12 |
Douglas M. Hayes | 9 |
Jonathan Zung | 9 |
Tonya Williams | 9 |
John Kober | 7 |
Luca Scavo | 7 |
Kenneth Walter Smith | 6 |
Thomas E. Naugle | 6 |
Jerome D. Brady | 6 |
- Borsa valori
- Insiders
- Stephen J. Carriere
- Connessioni Società